Stockreport

CervoMed to Participate in Upcoming Investor Conferences

CervoMed Inc.  (CRVO) 
PDF BOSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, [Read more]